Company profile: RedShift BioAnalytics
1.1 - Company Overview
Company description
- Provider of bioanalytical tools for the life science market, including the Aurora TX MMS instrument for structural and stability characterization of RNA, proteins, peptides and other biomolecules (with thermal ramping), the HaLCon Analyzer for on-demand protein titer measurement via trap-and-elute, delta MMS processing software, and StructIR Lab facilities for demonstrations and sample processing.
Products and services
- Microfluidic Modulation Spectroscopy (MMS): Quantum cascade laser-based technology integrating a microfluidic flow cell to deliver high-resolution secondary structure data for biomolecules, yielding precise conformational fingerprints
- Aurora TX: Custom-engineered MMS instrument enabling structural and stability characterization of RNA, proteins, and peptides, with thermal ramping to generate detailed unfolding analyses across biomolecules
- HaLCon Analyzer: Proprietary, trap-and-elute bioprocess analytics platform producing accurate on-demand protein titer measurements, enabling rapid quantification for process monitoring in bioproduction workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RedShift BioAnalytics
Atera Labs
HQ: Luxembourg
Website
- Description: Provider of advanced human tissue models and tissue engineering solutions, specializing in R&D, validation, manufacturing and commercialization to deliver reliable, cost-effective, high-quality test methods for product evaluation, gradually reducing and replacing animal experimentation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atera Labs company profile →
Xceleron
HQ: United States
Website
- Description: Provider of Accelerator Mass Spectrometry (AMS) services delivering ultra-sensitive analytical solutions for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xceleron company profile →
G-CON
HQ: United States
Website
- Description: Provider of off-site, prefabricated cleanroom units (PODs) for pharmaceutical development and manufacturing, including design, construction, installation and qualification, enabling faster deployment versus traditional cleanroom infrastructure to address rapidly changing requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full G-CON company profile →
Bio-Techne
HQ: United States
Website
- Description: Provider of tools for life science research, therapeutic manufacturing, and clinical diagnostics, including automated protein analysis (Simple Western), automated ELISA (Ella), bead-based multiplex assays (Luminex), non-viral gene transfer (TcBuster), recombinant antibodies, and custom bioactive compound libraries (Tocriscreen PRO) for research, drug discovery, and cell engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Techne company profile →
Grundium
HQ: Finland
Website
- Description: Provider of smart, portable digital microscope slide scanners leveraging state-of-the-art mobile technology for medical and research specialists. Offerings include Ocus 20 (20x) for fast imaging, intraoperative frozen sections and general pathology; Ocus 40 (40x) for high-resolution histopathology, tumor grading and cytology; and upcoming Ocus M 40 with four-slide tray, upgraded processor and 2TB storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Grundium company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RedShift BioAnalytics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RedShift BioAnalytics
2.2 - Growth funds investing in similar companies to RedShift BioAnalytics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RedShift BioAnalytics
4.2 - Public trading comparable groups for RedShift BioAnalytics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →